{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T05:13:19Z","timestamp":1782364399835,"version":"3.54.5"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:00:00Z","timestamp":1733788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:00:00Z","timestamp":1733788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1038\/s41366-024-01695-0","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T18:18:27Z","timestamp":1733854707000},"page":"688-697","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Investigation of pH-dependent 1H NMR urine metabolite profiles for diagnosis of obesity-related disordering"],"prefix":"10.1038","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3834-8937","authenticated-orcid":false,"given":"Dan-Ni","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5515-1493","authenticated-orcid":false,"given":"Erickson","family":"Fajiculay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Ping","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4248-0896","authenticated-orcid":false,"given":"Chun-Mei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8019-1772","authenticated-orcid":false,"given":"Li-Wen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3755-8230","authenticated-orcid":false,"given":"Der-Lii M.","family":"Tzou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,10]]},"reference":[{"key":"1695_CR1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/nbm.935","volume":"18","author":"ME Bollard","year":"2005","unstructured":"Bollard ME, Stanley EG, Lindon JC, Nicholson JK, Holmes E. NMR-based metabonomic approaches for evaluating physiological influences on biofluid composition. NMR Biomed. 2005;18:143\u201362.","journal-title":"NMR Biomed"},{"key":"1695_CR2","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1080\/01913120390231645","volume":"27","author":"J Hicks","year":"2003","unstructured":"Hicks J. Genome, proteome, and metabolome: where are we going? Ultrastruct Pathol. 2003;27:289\u201394.","journal-title":"Ultrastruct Pathol"},{"key":"1695_CR3","doi-asserted-by":"publisher","first-page":"6031","DOI":"10.1021\/acsomega.0c06209","volume":"6","author":"A Bhide","year":"2021","unstructured":"Bhide A, Ganguly A, Parupudi T, Ramasamy M, Muthukumar S, Prasad S. Next-generation continuous metabolite sensing toward emerging sensor needs. ACS Omega. 2021;6:6031\u201340.","journal-title":"ACS Omega"},{"key":"1695_CR4","doi-asserted-by":"publisher","first-page":"e73076","DOI":"10.1371\/journal.pone.0073076","volume":"8","author":"S Bouatra","year":"2013","unstructured":"Bouatra S, Aziat F, Mandal R, Guo AC, Wilson M, Knox C, et al. The human urine metabolome. PLoS ONE. 2013;8:e73076.","journal-title":"PLoS ONE"},{"key":"1695_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-60761-711-2_1","volume":"641","author":"G Echeverry","year":"2010","unstructured":"Echeverry G, Hortin GL, Rai AJ. Introduction to urinalysis: historical perspectives and clinical application. Methods Mol Biol. 2010;641:1\u201312.","journal-title":"Methods Mol Biol"},{"key":"1695_CR6","first-page":"1153","volume":"71","author":"JA Simerville","year":"2005","unstructured":"Simerville JA, Maxted WC, Pahira JJ. Urinalysis: a comprehensive review. Am Fam Physician. 2005;71:1153\u201362.","journal-title":"Am Fam Physician"},{"key":"1695_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/bjc.2015.414","volume":"114","author":"AW Chan","year":"2016","unstructured":"Chan AW, Mercier P, Schiller D, Bailey R, Robbins S, Eurich DT, et al. 1H-NMR urinary metabolomic profiling for diagnosis of gastric cancer. Br J Cancer. 2016;114:59\u201362.","journal-title":"Br J Cancer"},{"key":"1695_CR8","doi-asserted-by":"publisher","first-page":"105819","DOI":"10.18632\/oncotarget.22402","volume":"8","author":"Z Wang","year":"2017","unstructured":"Wang Z, Lin Y, Liang J, Huang Y, Ma C, Liu X, et al. NMR-based metabolomic techniques identify potential urinary biomarkers for early colorectal cancer detection. Oncotarget. 2017;8:105819.","journal-title":"Oncotarget"},{"key":"1695_CR9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3390\/cancers12010241","volume":"12","author":"A Casadei-Gardini","year":"2020","unstructured":"Casadei-Gardini A, Del Coco L, Marisi G, Conti F, Rovesti G, Ulivi P, et al. (1)H-NMR based serum metabolomics highlights different specific biomarkers between early and advanced hepatocellular carcinoma stages. Cancers. 2020;12:241.","journal-title":"Cancers"},{"key":"1695_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-74880-6","volume":"10","author":"C Lema","year":"2020","unstructured":"Lema C, Andr\u00e9s M, Aguad\u00e9-Bruix S, Consegal M, Rodriguez-Sinovas A, Benito B, et al. 1H NMR serum metabolomic profiling of patients at risk of cardiovascular diseases performing stress test. Sci Rep. 2020;10:17838.","journal-title":"Sci Rep"},{"key":"1695_CR11","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.3390\/cancers13225845","volume":"13","author":"G Corona","year":"2021","unstructured":"Corona G, Di Gregorio E, Vignoli A, Muraro E, Steffan A, Miolo G. 1H-NMR plasma lipoproteins profile analysis reveals lipid metabolism alterations in HER2-positive breast cancer patients. Cancers. 2021;13:5845.","journal-title":"Cancers"},{"key":"1695_CR12","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.trac.2007.12.001","volume":"27","author":"DS Wishart","year":"2008","unstructured":"Wishart DS. Quantitative metabolomics using NMR. Trends Anal Chem. 2008;27:228\u201337.","journal-title":"Trends Anal Chem"},{"key":"1695_CR13","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.1021\/ac060209g","volume":"78","author":"AM Weljie","year":"2006","unstructured":"Weljie AM, Newton J, Mercier P, Carlson E, Slupsky CM. Targeted profiling: quantitative analysis of 1H NMR metabolomics data. Anal Chem. 2006;78:4430\u201342.","journal-title":"Anal Chem"},{"key":"1695_CR14","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1093\/jat\/31.8.486","volume":"31","author":"JD Cook","year":"2007","unstructured":"Cook JD, Strauss KA, Caplan YH, LoDico CP, Bush DM. Urine pH: the effects of time and temperature after collection. J Anal Toxicol. 2007;31:486\u201396.","journal-title":"J Anal Toxicol"},{"key":"1695_CR15","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s11426-008-0031-6","volume":"51","author":"W Yang","year":"2008","unstructured":"Yang W, Wang Y, Zhou Q, Tang H. Analysis of human urine metabolites using SPE and NMR spectroscopy. Sci China Ser B Chem. 2008;51:218\u201325.","journal-title":"Sci China Ser B Chem"},{"key":"1695_CR16","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.aca.2010.11.027","volume":"685","author":"A Beneduci","year":"2011","unstructured":"Beneduci A, Chidichimo G, Dardo G, Pontoni G. Highly routinely reproducible alignment of 1H NMR spectral peaks of metabolites in huge sets of urines. Anal Chim Acta. 2011;685:186\u201395.","journal-title":"Anal Chim Acta"},{"key":"1695_CR17","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/mrm.1910360505","volume":"36","author":"JJ Ackerman","year":"1996","unstructured":"Ackerman JJ, Soto GE, Spees WM, Zhu Z, Evelhoch JL. The NMR chemical shift pH measurement revisited: analysis of error and modeling of a pH dependent reference. Magn Reson Med. 1996;36:674\u201383.","journal-title":"Magn Reson Med"},{"key":"1695_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-016-1101-y","volume":"12","author":"GD Tredwell","year":"2016","unstructured":"Tredwell GD, Bundy JG, De Iorio M, Ebbels TMD. Modelling the acid\/base 1H NMR chemical shift limits of metabolites in human urine. Metabolomics. 2016;12:152.","journal-title":"Metabolomics"},{"key":"1695_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmr.2022.107335","volume":"345","author":"F Bhinderwala","year":"2022","unstructured":"Bhinderwala F, Roth HE, Noel H, Feng D, Powers R. Chemical shift variations in common metabolites. J Magn Reson. 2022;345:107335.","journal-title":"J Magn Reson"},{"key":"1695_CR20","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1021\/ac061354x","volume":"79","author":"M Lauridsen","year":"2007","unstructured":"Lauridsen M, Hansen SH, Jaroszewski JW, Cornett C. Human urine as test material in 1H NMR-based metabonomics: recommendations for sample preparation and storage. Anal Chem. 2007;79:1181\u20136.","journal-title":"Anal Chem"},{"key":"1695_CR21","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1039\/b818802e","volume":"134","author":"C Xiao","year":"2009","unstructured":"Xiao C, Hao F, Qin X, Wang Y, Tang H. An optimized buffer system for NMR-based urinary metabonomics with effective pH control, chemical shift consistency and dilution minimization. Analyst. 2009;134:916\u201325.","journal-title":"Analyst"},{"key":"1695_CR22","doi-asserted-by":"crossref","unstructured":"Lindon JC, Nicholson JK, Everett JR. NMR spectroscopy of biofluids. In: Webb GA, editor. Annu Rep NMR Spectrosc., Academic Press, London; 1999;38:1\u201388.","DOI":"10.1016\/S0066-4103(08)60035-6"},{"key":"1695_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3390\/metabo14050275","volume":"14","author":"A Trimigno","year":"2024","unstructured":"Trimigno A, Holderman NR, Dong C, Boardman KD, Zhao J, O\u2019Day EM. NMR precision metabolomics: dynamic peak sum thresholding and navigators for highly standardized and reproducible metabolite profiling of clinical urine samples. Metabolites. 2024;14:275.","journal-title":"Metabolites"},{"key":"1695_CR24","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1002\/elps.201500031","volume":"36","author":"A Gil","year":"2015","unstructured":"Gil A, Siegel D, Permentier H, Reijngoud DJ, Dekker F, Bischoff R. Stability of energy metabolites\u2014an often overlooked issue in metabolomics studies: a review. Electrophoresis. 2015;36:2156\u201369.","journal-title":"Electrophoresis"},{"key":"1695_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-018-1351-y","volume":"14","author":"L Ye","year":"2018","unstructured":"Ye L, De Iorio M, Ebbels TMD. Bayesian estimation of the number of protonation sites for urinary metabolites from NMR spectroscopic data. Metabolomics. 2018;14:56.","journal-title":"Metabolomics"},{"key":"1695_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-019-0185-y","volume":"2","author":"IJ Miller","year":"2019","unstructured":"Miller IJ, Peters SR, Overmyer KA, Paulson BR, Westphall MS, Coon JJ. Real-time health monitoring through urine metabolomics. NPJ Digital Med. 2019;2:109.","journal-title":"NPJ Digital Med"},{"key":"1695_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1738","volume":"9","author":"T Wang","year":"2021","unstructured":"Wang T, Tang L, Lin R, He D, Wu Y, Zhang Y, et al. Individual variability in human urinary metabolites identifies age\u2010related, body mass index\u2010related, and sex\u2010related biomarkers. Mol Genet Genom Med. 2021;9:e1738.","journal-title":"Mol Genet Genom Med"},{"key":"1695_CR28","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s43016-020-0093-y","volume":"1","author":"JM Posma","year":"2020","unstructured":"Posma JM, Garcia-Perez I, Frost G, Aljuraiban GS, Chan Q, Van Horn L, et al. Nutriome\u2013metabolome relationships provide insights into dietary intake and metabolism. Nat Food. 2020;1:426\u201336.","journal-title":"Nat Food"},{"key":"1695_CR29","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1111\/jdi.13284","volume":"11","author":"Y Higashiura","year":"2020","unstructured":"Higashiura Y, Tanaka M, Furuhashi M, Koyama M, Ohnishi H, Numata K, et al. Low urine pH predicts new onset of diabetes mellitus during a 10\u2010year period in men: BOREAS\u2010DM1 study. J Diabetes Investig. 2020;11:1490\u20137.","journal-title":"J Diabetes Investig"},{"key":"1695_CR30","doi-asserted-by":"publisher","first-page":"883","DOI":"10.2215\/CJN.00670207","volume":"2","author":"NM Maalouf","year":"2007","unstructured":"Maalouf NM, Cameron MA, Moe OW, Adams-Huet B, Sakhaee K. Low urine pH: a novel feature of the metabolic syndrome. Clin J Am Soc Nephrol. 2007;2:883\u20138.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1695_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1159\/000330487","volume":"35","author":"N Nakanishi","year":"2012","unstructured":"Nakanishi N, Fukui M, Tanaka M, Toda H, Imai S, Yamazaki M, et al. Low urine pH is a predictor of chronic kidney disease. Kidney Blood Press Res. 2012;35:77\u201381.","journal-title":"Kidney Blood Press Res"},{"key":"1695_CR32","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1007\/s11306-014-0746-7","volume":"11","author":"AH Emwas","year":"2015","unstructured":"Emwas AH, Luchinat C, Turano P, Tenori L, Roy R, Salek RM, et al. Standardizing the experimental conditions for using urine in NMR-based metabolomic studies with a particular focus on diagnostic studies: a review. Metabolomics. 2015;11:872\u201394.","journal-title":"Metabolomics"},{"key":"1695_CR33","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1002\/jps.2600511117","volume":"51","author":"HB Kostenbauder","year":"1962","unstructured":"Kostenbauder HB, Portnoff JB, Swintosky JV. Control of urine pH and its effect on sulfaethidole excretion in humans. J Pharm Sci. 1962;51:1084\u20139.","journal-title":"J Pharm Sci"},{"key":"1695_CR34","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1159\/000281730","volume":"45","author":"VM Bilobrov","year":"1990","unstructured":"Bilobrov VM, Chugaj AV, Bessarabov VI. Urine pH variation dynamics in healthy individuals and stone formers. Urol Int. 1990;45:326\u201331.","journal-title":"Urol Int"},{"key":"1695_CR35","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1021\/acs.jproteome.5b00885","volume":"15","author":"A-H Emwas","year":"2016","unstructured":"Emwas A-H, Roy R, McKay RT, Ryan D, Brennan L, Tenori L, et al. Recommendations and standardization of biomarker quantification using NMR-based metabolomics with particular focus on urinary analysis. J Proteome Res. 2016;15:360\u201373.","journal-title":"J Proteome Res"},{"key":"1695_CR36","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10858-011-9489-1","volume":"49","author":"P Bernini","year":"2011","unstructured":"Bernini P, Bertini I, Luchinat C, Nincheri P, Staderini S, Turano P. Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks. J Biomol NMR. 2011;49:231\u201343.","journal-title":"J Biomol NMR"},{"issue":"Suppl 1","key":"1695_CR37","doi-asserted-by":"publisher","first-page":"D603","DOI":"10.1093\/nar\/gkn810","volume":"37","author":"DS Wishart","year":"2009","unstructured":"Wishart DS, Knox C, Guo AC, Eisner R, Young N, Gautam B, et al. HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res. 2009;37(Suppl 1):D603\u201310.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"1695_CR38","doi-asserted-by":"publisher","first-page":"e0256409","DOI":"10.1371\/journal.pone.0256409","volume":"17","author":"E Fajiculay","year":"2022","unstructured":"Fajiculay E, Hsu CP. BioSANS: a software package for symbolic and numeric biological simulation. PLoS ONE. 2022;17(4):e0256409.","journal-title":"PLoS ONE"},{"key":"1695_CR39","doi-asserted-by":"publisher","unstructured":"Wu DN, Fajiculay E. Supporting information_pH intelligence program [Mendeley Data]. V1. 2024. https:\/\/doi.org\/10.17632\/p9d6rnknm5.1.","DOI":"10.17632\/p9d6rnknm5.1"},{"key":"1695_CR40","doi-asserted-by":"publisher","DOI":"10.1177\/0300060519898615","volume":"48","author":"J Lee","year":"2020","unstructured":"Lee J, Chang HK, Lee S. Association of low urine pH as a metabolic feature with abdominal obesity. J Int Med Res. 2020;48:0300060519898615.","journal-title":"J Int Med Res"},{"key":"1695_CR41","unstructured":"Chenomix NMR suite. Chenomix Inc., Edmonton, Alberta, Canada. 2009. http:\/\/www.chenomx.com."},{"key":"1695_CR42","unstructured":"Roberts JD, Caserio MC. Basic principles of organic chemistry. 2nd ed. WA Benjamin Inc., Menlo park, CA; 1977. pp. 1157\u201360."},{"key":"1695_CR43","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.supflu.2003.12.009","volume":"31","author":"KM Benjamin","year":"2004","unstructured":"Benjamin KM, Savage PE. Hydrothermal reactions of methylamine. J Supercrit Fluids. 2004;31:301\u201311.","journal-title":"J Supercrit Fluids"},{"key":"1695_CR44","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1289\/ehp.7337","volume":"113","author":"DB Barr","year":"2005","unstructured":"Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL. Urinary creatinine concentrations in the US population: implications for urinary biologic monitoring measurements. Environ Health Perspect. 2005;113:192\u2013200.","journal-title":"Environ Health Perspect"},{"key":"1695_CR45","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.forsciint.2009.01.010","volume":"186","author":"T Arndt","year":"2009","unstructured":"Arndt T. Urine-creatinine concentration as a marker of urine dilution: reflections using a cohort of 45,000 samples. Forensic Sci Int. 2009;186:48\u201351.","journal-title":"Forensic Sci Int"},{"key":"1695_CR46","first-page":"42","volume":"55","author":"NB Talbot","year":"1938","unstructured":"Talbot NB, Broughton F. Measurement of obesity by the creatinine coefficient. Am J Dis Child. 1938;55:42\u201350.","journal-title":"Am J Dis Child"},{"key":"1695_CR47","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1152\/physiolgenomics.00194.2006","volume":"29","author":"RM Salek","year":"2007","unstructured":"Salek RM, Maguire ML, Bentley E, Rubtsov DV, Hough T, Cheeseman M, et al. A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. Physiol Genomics. 2007;29:99\u2013108.","journal-title":"Physiol Genomics"},{"key":"1695_CR48","doi-asserted-by":"crossref","unstructured":"Ross A, Schlotterbeck G, Dieterle F, Senn H. Chapter 3\u2014NMR spectroscopy techniques for application to metabonomics. In: Lindon JC, Nicholson JK, Holmes E, editors. The handbook of metabonomics and metabolomics. Elsevier BV, Oxford, UK; 2007. pp. 55\u2013112.","DOI":"10.1016\/B978-044452841-4\/50004-7"},{"key":"1695_CR49","doi-asserted-by":"publisher","first-page":"4209","DOI":"10.1039\/c2an35392j","volume":"137","author":"L Jiang","year":"2012","unstructured":"Jiang L, Huang J, Wang Y, Tang H. Eliminating the dication-induced intersample chemical-shift variations for NMR-based biofluid metabonomic analysis. Analyst. 2012;137:4209\u201319.","journal-title":"Analyst"},{"key":"1695_CR50","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s11306-008-0121-7","volume":"4","author":"VM Asiago","year":"2008","unstructured":"Asiago VM, Nagana Gowda G, Zhang S, Shanaiah N, Clark J, Raftery D. Use of EDTA to minimize ionic strength dependent frequency shifts in the 1H NMR spectra of urine. Metabolomics. 2008;4:328\u201336.","journal-title":"Metabolomics"},{"key":"1695_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11306-016-1101-y","volume":"12","author":"GD Tredwell","year":"2016","unstructured":"Tredwell GD, Bundy JG, De Iorio M, Ebbels TM. Modelling the acid\/base 1 H NMR chemical shift limits of metabolites in human urine. Metabolomics. 2016;12:1\u201310.","journal-title":"Metabolomics"},{"key":"1695_CR52","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/obr.12843","volume":"20","author":"R Zhuang","year":"2019","unstructured":"Zhuang R, Ge X, Han L, Yu P, Gong X, Meng Q, et al. Gut microbe-generated metabolite trimethylamine N-oxide and the risk of diabetes: a systematic review and dose-response meta-analysis. Obes Rev. 2019;20:883\u201394.","journal-title":"Obes Rev"},{"key":"1695_CR53","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.3390\/nu10121971","volume":"10","author":"L Barrea","year":"2018","unstructured":"Barrea L, Annunziata G, Muscogiuri G, Di Somma C, Laudisio D, Maisto M, et al. Trimethylamine-N-oxide (TMAO) as novel potential biomarker of early predictors of metabolic syndrome. Nutrients. 2018;10:1971.","journal-title":"Nutrients"},{"key":"1695_CR54","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12944-022-01673-3","volume":"21","author":"X Xiong","year":"2022","unstructured":"Xiong X, Zhou J, Fu Q, Xu X, Wei S, Yang S, et al. The associations between TMAO-related metabolites and blood lipids and the potential impact of rosuvastatin therapy. Lipids Health Dis. 2022;21:60.","journal-title":"Lipids Health Dis"},{"key":"1695_CR55","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1053\/j.ajkd.2022.02.016","volume":"80","author":"H Sapa","year":"2022","unstructured":"Sapa H, Guti\u00e9rrez OM, Shlipak MG, Katz R, Ix JH, Sarnak MJ, et al. Association of uremic solutes with cardiovascular death in diabetic kidney disease. Am J Kidney Dis. 2022;80:502\u201312.e1.","journal-title":"Am J Kidney Dis"},{"key":"1695_CR56","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jpba.2013.02.014","volume":"78-79","author":"X Song","year":"2013","unstructured":"Song X, Wang J, Wang P, Tian N, Yang M, Kong L. \u00b9H NMR-based metabolomics approach to evaluate the effect of Xue-Fu-Zhu-Yu decoction on hyperlipidemia rats induced by high-fat diet. J Pharm Biomed Anal. 2013;78-79:202\u201310.","journal-title":"J Pharm Biomed Anal"},{"key":"1695_CR57","doi-asserted-by":"publisher","first-page":"833","DOI":"10.2337\/dc15-2251","volume":"39","author":"M Guasch-Ferr\u00e9","year":"2016","unstructured":"Guasch-Ferr\u00e9 M, Hruby A, Toledo E, Clish CB, Mart\u00ednez-Gonz\u00e1lez MA, Salas-Salvad\u00f3 J, et al. Metabolomics in prediabetes and diabetes: a systematic review and meta-analysis. Diabetes Care. 2016;39:833\u201346.","journal-title":"Diabetes Care"},{"key":"1695_CR58","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/hep.29465","volume":"67","author":"M Gaggini","year":"2018","unstructured":"Gaggini M, Carli F, Rosso C, Buzzigoli E, Marietti M, Della Latta V, et al. Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance. Hepatology. 2018;67:145\u201358.","journal-title":"Hepatology"},{"key":"1695_CR59","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1210\/jc.2004-0317","volume":"90","author":"RM Lewis","year":"2005","unstructured":"Lewis RM, Godfrey KM, Jackson AA, Cameron IT, Hanson MA. Low serine hydroxymethyltransferase activity in the human placenta has important implications for fetal glycine supply. J Clin Endocrinol Metab. 2005;90:1594\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"1695_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4083","volume":"5","author":"A Mardinoglu","year":"2014","unstructured":"Mardinoglu A, Agren R, Kampf C, Asplund A, Uhlen M, Nielsen J. Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease. Nat Commun. 2014;5:3083.","journal-title":"Nat Commun"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41366-024-01695-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-024-01695-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-024-01695-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T11:11:13Z","timestamp":1744715473000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41366-024-01695-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,10]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["1695"],"URL":"https:\/\/doi.org\/10.1038\/s41366-024-01695-0","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,10]]},"assertion":[{"value":"22 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The access and use of Taiwan Biobank data as well as urine samples were officially approved by the Ethics and Governance Council (EGC) of Taiwan Biobank (Reference: TWBR11204-02) and the Institutional Review Board (IRB) of the Chang Gung Medical Foundation (Reference: 202300164B0). All methods involving in this study have been performed in accordance with the 1964 Helsinki Declaration and its later amendments. Informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}